SMC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.098100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.016980E-01
Normal-vs-Stage2
2.811700E-02
Normal-vs-Stage3
1.878820E-03
Normal-vs-Stage4
7.213900E-02
Stage1-vs-Stage2
8.685600E-01
Stage1-vs-Stage3
5.132500E-02
Stage1-vs-Stage4
8.500800E-01
Stage2-vs-Stage3
2.705600E-02
Stage2-vs-Stage4
7.259400E-01
Stage3-vs-Stage4
8.500200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.762220E-02
Normal-vs-AfricanAmerican
2.304200E-01
Normal-vs-Asian
1.101190E-01
Caucasian-vs-AfricanAmerican
5.648800E-01
Caucasian-vs-Asian
4.200000E-01
AfricanAmerican-vs-Asian
9.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.649600E-02
Normal-vs-Female
1.216280E-02
Male-vs-Female
5.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.183700E-02
Normal-vs-Age(41-60Yrs)
7.560100E-02
Normal-vs-Age(61-80Yrs)
1.405860E-02
Normal-vs-Age(81-100Yrs)
8.858900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.741370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.658200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.095000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.998300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.652100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.165600E-02
Normal-vs-Daily Drinker
1.638480E-02
Normal-vs-Weekly Drinker
2.276200E-02
Normal-vs-Occasional Drinker
2.469900E-02
Normal-vs-Social Drinker
2.053900E-02
Non Drinker-vs-Daily Drinker
7.565600E-01
Non Drinker-vs-Weekly Drinker
5.454000E-01
Non Drinker-vs-Occasional Drinker
7.757400E-01
Non Drinker-vs-Social Drinker
3.618000E-01
Daily Drinker-vs-Weekly Drinker
7.421400E-01
Daily Drinker-vs-Occasional Drinker
5.759000E-01
Daily Drinker-vs-Social Drinker
2.385800E-01
Weekly Drinker-vs-Occasional Drinker
4.199000E-01
Weekly Drinker-vs-Social Drinker
1.708960E-01
Occasional Drinker-vs-Social Drinker
5.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.261970E-01
Normal-vs-Grade 2
1.164410E-02
Normal-vs-Grade 3
1.167980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.944800E-01
Grade 1-vs-Grade 3
2.033400E-01
Grade 1-vs-Grade 4
1.261970E-01
Grade 2-vs-Grade 3
7.364600E-01
Grade 2-vs-Grade 4
1.164410E-02
Grade 3-vs-Grade 4
1.167980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.115900E-03
Normal-vs-NonDiabetic
1.924340E-02
Diabetic-vs-NonDiabetic
1.804570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.792150E-02
Normal-vs-NoPancreatitis
1.554030E-02
Pancreatitis-vs-NoPancreatitis
6.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.386300E-02
Normal-vs-N1
2.441700E-02
N0-vs-N1
7.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.323600E-02
Normal-vs-TP53-NonMutant
1.015040E-01
TP53-Mutant-vs-TP53-NonMutant
9.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
